Vir Biotechnology (VIR) Depreciation and Depletion (2023 - 2026)

Vir Biotechnology has disclosed Depreciation and Depletion across 4 years of filings, most recently posting $2.7 million for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $2.7 million, down 3.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.3 million (down 10.32% YoY), and the FY2025 annual result was $11.4 million, down 19.72% from the prior year.
• Depreciation and Depletion came in at $2.7 million for Q1 2026 at Vir Biotechnology, down from $2.8 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $5.5 million in Q1 2023 to a low of $2.7 million in Q4 2024.
• The 4-year median for Depreciation and Depletion is $2.9 million (2024), against an average of $3.6 million.
• Across the five-year window, Depreciation and Depletion slumped 37.21% in 2024 and advanced 3.7% in 2025, its largest moves.
• Vir Biotechnology's Depreciation and Depletion stood at $4.3 million in 2023, then plunged by 37.21% to $2.7 million in 2024, then rose by 3.7% to $2.8 million in 2025, then decreased by 3.57% to $2.7 million in 2026.
• The last three Depreciation and Depletion figures came in at $2.7 million (Q1 2026), $2.8 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.